piracetam has been researched along with aniracetam in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Angelucci, L; Calvisi, P; Catini, R; Cosentino, U; Cozzolino, R; De Witt, P; Ghirardi, O; Giannessi, F; Giuliani, A; Guaraldi, D | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ahmed, AH; Oswald, RE | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Hadjiivanova, CI; Petkov, VD; Petkov, VV; Stancheva, SL | 1 |
| Genkova-Papasova, MG; Lazarova-Bakarova, MB | 1 |
| Borkowski, J; Ducret, T; Mondadori, C | 1 |
| Ducret, T; Mondadori, C; Petschke, F | 1 |
| Genkova-Papasova, M; Lazarova-Bakurova, M | 1 |
| Getova, D; Mosharrof, AH; Petkov, VD | 1 |
| Pugsley, TA; Shih, YH | 1 |
| Kehayov, R; Petkov, VD | 1 |
| Furukawa, T; Inoue, T; Tanaka, M; Yamada, K | 1 |
| Jänicke, B; Wrobel, D | 1 |
| Grahovska, T; Konstantinova, E; Petkov, VD; Petkov, VV; Stancheva, S | 1 |
| Grünberger, J; Linzmayer, L; Saletu, B | 1 |
| Hamelin, SM; Lehmann, JC | 1 |
| Bartolini, A; Galeotti, N; Ghelardini, C | 1 |
| Nishizaki, T; Nomura, T | 1 |
| Vaglenova, J; Vesselinov Petkov, V | 1 |
| Cecil, A; Crites, G; Goldenberg, R; Knapp, RJ; Malatynska, E; Miller, C; Shuck, C; Watkins, J | 1 |
| Anastasio, NC; Cunningham, KA; Davis-Reyes, BD; Smith, AE; Xu, J; Zhou, J | 1 |
1 trial(s) available for piracetam and aniracetam
| Article | Year |
|---|---|
Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
Topics: Aged; Analysis of Variance; Brain; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Electroencephalography; Female; Humans; Male; Middle Aged; Piracetam; Psychometrics; Pyrrolidinones; Random Allocation | 1980 |
21 other study(ies) available for piracetam and aniracetam
| Article | Year |
|---|---|
Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams.
Topics: Amnesia; Animals; Brain; Cholinesterase Inhibitors; Drug Design; Electroshock; In Vitro Techniques; Lactams; Male; Mice; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Inbred F344; Scopolamine; Structure-Activity Relationship | 1993 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors.
Topics: Allosteric Regulation; Binding Sites; Humans; Mutagenesis, Insertional; Nootropic Agents; Piracetam; Pyrrolidinones; Receptors, AMPA; X-Ray Diffraction | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Age-related changes of the effects of a group of nootropic drugs on the content of rat brain biogenic monoamines.
Topics: Aging; Animals; Biogenic Monoamines; Brain Chemistry; Male; Piracetam; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1991 |
Influence of nootropic drugs on the memory-impairing effect of clonidine in albino rats.
Topics: Animals; Clonidine; Drug Interactions; Male; Meclofenoxate; Memory; Piperazines; Piracetam; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Inbred Strains | 1989 |
The memory-enhancing effects of the piracetam-like nootropics are dependent on experimental parameters.
Topics: Animals; Avoidance Learning; Dose-Response Relationship, Drug; Male; Memory; Mental Recall; Mice; Mice, Inbred Strains; Piracetam; Pyrrolidines; Pyrrolidinones | 1989 |
Blockade of the nootropic action of piracetam-like nootropics by adrenalectomy: an effect of dosage?
Topics: Adrenalectomy; Animals; Arousal; Dose-Response Relationship, Drug; Male; Memory; Mental Recall; Mice; Mice, Inbred Strains; Piracetam; Pyrrolidines; Pyrrolidinones; Retention, Psychology | 1989 |
Influence of nootropic drugs on the memory-impairing effect of diethyldithiocarbamate and clonidine in "step down" passive avoidance in albino rats.
Topics: Animals; Avoidance Learning; Clonidine; Ditiocarb; Drug Interactions; Male; Meclofenoxate; Memory; Norepinephrine; Piperazines; Piracetam; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Inbred Strains; Synaptic Transmission | 1988 |
A study of nootropic drugs for anti-anxiety action.
Topics: Animals; Anti-Anxiety Agents; Central Nervous System Agents; Male; Meclofenoxate; Panax; Piracetam; Plant Extracts; Plants, Medicinal; Pyrrolidinones; Rats | 1987 |
The effects of various cognition-enhancing drugs on in vitro rat hippocampal synaptosomal sodium dependent high affinity choline uptake.
Topics: Adrenocorticotropic Hormone; Animals; Choline; Cognition; Hippocampus; In Vitro Techniques; Male; Meclofenoxate; Piracetam; Pyrrolidinones; Rats; Receptors, Muscarinic; Scopolamine; Sodium; Synaptosomes | 1985 |
Individually-determined differences in the effects of psychotropic drugs on memory (experiments on rats).
Topics: Amphetamine; Animals; Avoidance Learning; Dose-Response Relationship, Drug; Male; Meclofenoxate; Memory; Piracetam; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Inbred Strains; Retention, Psychology | 1987 |
Prolongation of latencies for passive avoidance responses in rats treated with aniracetam or piracetam.
Topics: Animals; Avoidance Learning; Male; Motor Activity; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Reaction Time | 1985 |
Changes in motor activity with age and the effects of pharmacologic treatment.
Topics: Aging; Animals; Body Weight; Dextroamphetamine; Dihydroergotoxine; Female; Meclofenoxate; Motor Activity; Piracetam; Pyrithioxin; Pyrrolidinones; Rats; Rats, Inbred Strains | 1984 |
Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam.
Topics: Animals; Biogenic Amines; Brain; Brain Stem; Cerebral Cortex; Corpus Striatum; Dopamine; Hypothalamus; Male; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Serotonin | 1984 |
Effects of putative cognition enhancers on the NMDA receptor by [3H]MK801 binding.
Topics: Animals; Binding, Competitive; Cognition; Cycloserine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Kynurenic Acid; Piracetam; Pyrrolidinones; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1995 |
Piracetam and aniracetam antagonism of centrally active drug-induced antinociception.
Topics: Analgesics; Analgesics, Opioid; Animals; Baclofen; Bicuculline; Male; Mice; Morphine; Nootropic Agents; Pain Measurement; Pain Threshold; Picrotoxin; Piracetam; Postural Balance; Pyrrolidinones; Receptors, GABA-B | 1996 |
Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
Topics: Animals; Bungarotoxins; Gene Expression; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Mecamylamine; Membrane Potentials; Neurons; Nicotinic Antagonists; Nootropic Agents; Oocytes; Patch-Clamp Techniques; Piracetam; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Nicotinic; Synaptic Transmission; Xenopus | 2000 |
Can nootropic drugs be effective against the impact of ethanol teratogenicity on cognitive performance?
Topics: Alcohol-Induced Disorders, Nervous System; Animals; Disease Models, Animal; Female; Learning Disabilities; Male; Meclofenoxate; Memory Disorders; Nootropic Agents; Piracetam; Pregnancy; Prenatal Exposure Delayed Effects; Pyrrolidinones; Rats; Rats, Wistar | 2001 |
Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model.
Topics: Animals; Antidepressive Agents; Competitive Behavior; Desipramine; Diazepam; Dioxoles; Dose-Response Relationship, Drug; Fluoxetine; Injections, Intraperitoneal; Male; Maze Learning; Models, Animal; Nootropic Agents; Piperidines; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley | 2002 |
Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats.
Topics: Animals; Antidepressive Agents; Cognition; Dose-Response Relationship, Drug; Glutamic Acid; Impulsive Behavior; Ketamine; Mental Disorders; Neuronal Plasticity; Nootropic Agents; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2021 |